Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935800 · ClinicalTrials.gov registry record
The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates
A clinical trial, sponsored by Methodist Health System.
- Active
- Registry status
- 208
- Enrollment target
NCT05935800: Active study, sponsored by Methodist Health System.
NCT05935800 is a clinical trial that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05935800 is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 208 participants
- Enrollment target
Study Summary
Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decreased patient strength and vitality.
Primary Outcome
To determine the impact of the COVID-19 pandemic on the prevalence of sarcopenia and frailty in patients undergoing liver transplant evaluation at Methodist Dallas Medical Center
Interventions
- BEHAVIORAL COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2028-04-19 |
What the registry record for NCT05935800 still lists
NCT05935800 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC is the first listed.
NCT05935800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05935800 about?
NCT05935800 is a clinical study titled "The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates". Frailty is associated with higher rates of morbidity, mortality, and failure to rescue after major surgical procedures. Sarcopenia is degenerative loss of skeletal muscle mass and strength. It is a key component of physical frailty and is associated with poorer post-surgical outcomes due to decrease...
What is the current status of trial NCT05935800?
This trial is currently active not recruiting. The enrollment target is 208 participants. The study started on 2022-04-19. Estimated completion is 2028-04-19.
What interventions are being tested in trial NCT05935800?
The interventions under investigation include: COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC (BEHAVIORAL).
Who is sponsoring clinical trial NCT05935800?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI